| Previous Close | 0.7600 |
| Open | 0.7600 |
| Bid | 0.7200 x 0 |
| Ask | 0.7500 x 0 |
| Day's Range | 0.7200 - 0.7600 |
| 52 Week Range | 0.2100 - 0.8000 |
| Volume | 28,754 |
| Avg. Volume | 83,412 |
| Market Cap | 30.472M |
| Beta (5Y Monthly) | 1.55 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4110 |
| Earnings Date | Nov. 27, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- ACCESSWIRE
Pond Technologies Announces Grant of Stock Options
MARKHAM, ON / ACCESSWIRE / April 1, 2021 / Pond Technologies Holdings Inc.V:POND); (OTCQB:PNDHF); (FSE:400), an ESG company addressing global sustainability challenges of wellness and climate change announces that on March 31, 2021 it granted an aggregate of 1,495,000, stock options (the "Options") to eligible executives, employees and consultants under the Corporation's existing stock option plan.
- ACCESSWIRE
Pond Technologies Announces Nigel deGruyther, B.Sc., MBA, Joins Pond as Vice President of Pond Biotech
Former Head of Business Development at Cynapsus Therapeutics Broadens Pond Executive Leadership Team as Company Builds Foundation for GrowthMARKHAM, ON / ACCESSWIRE / March 30, 2021 / Pond Technologies Holdings Inc.V:POND)(OTCQB:PNDHF)(FSE:400), an ESG company addressing global sustainability challenges of wellness and climate change is pleased to announce the appointment of Nigel deGruyther, former head of Business Development, Cynapsus Therapeutics, as Vice President of Pond Biotech.
- ACCESSWIRE
Pond Technologies Announces Extension to Crystal Wealth Loan
MARKHAM, ON / ACCESSWIRE / March 25, 2021/ Pond Technologies Holdings Inc.V:POND) (OTCQB:PNDHF) (FSE:400), an ESG company addressing global sustainability challenges of wellness and climate change, announces that on March 24, 2021 it entered into an amending agreement with Grant Thornton Limited, in its capacity as receiver and manager of Crystal Wealth Management System Limited, to amend certain terms relating to Pond's obligations under its existing loan arrangements with Grant Thornton.
